This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Ucb Pharma Gmbh, Schwarz Pharma Ag, Other. Active years: 1994-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Leverkussen, DE (2015)
- Leverkusen, DE (1994 - 2017)
Company Filing History:
3 out of 64 
1 out of 45 
1 out of 834,659 Years Active: 1994-2017
Title: Ralf Kanzler: Innovator in Pharmaceutical Processes
Introduction
Ralf Kanzler is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug preparation. With a total of 5 patents to his name, Kanzler's work has had a meaningful impact on the industry.
Latest Patents
One of Ralf Kanzler's latest patents is a process for preparing lacosamide. This invention provides a method for the preparation of lacosamide in substantially optically pure form. The process involves several key steps: first, the resolution of O-methyl-D,L-serine to yield O-methyl-D-serine in substantially optically pure form. Next, the acetylation of O-methyl-D-serine is performed to provide the N-acetyl derivative in substantially optically pure form. Following this, the carboxy group of the compound is activated, and finally, the compound is reacted with benzylamine.
Career Highlights
Throughout his career, Ralf Kanzler has worked with prominent companies in the pharmaceutical sector, including UCB Pharma GmbH and Schwarz Pharma AG. His expertise in drug formulation and process optimization has been instrumental in advancing pharmaceutical technologies.
Collaborations
Ralf Kanzler has collaborated with several professionals in the industry, including Alain Merschaert and Joerg Hamann. These collaborations have contributed to the successful development of innovative pharmaceutical processes.
Conclusion
Ralf Kanzler's contributions to the field of pharmaceuticals through his innovative processes and collaborations highlight his role as a significant inventor. His work continues to influence the development of effective pharmaceutical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile